36 , 37 This may be highly significant when contemplating peptide-based cancer immunotherapies targeting WT1. 38 Clearly, a better understanding of the relationship between WT1 and breast cancer is required to inform the development of immunotherapy for targeting WT-positive tumour cells in this condition.
← all excerpts
WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.
1
—
—